Literature DB >> 20949625

The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors.

Lokesh Dalasanur Nagaprashantha1, Rit Vatsyayan, Poorna Chandra Rao Lelsani, Sanjay Awasthi, Sharad S Singhal.   

Abstract

Normal cells continuously monitor the nature of their respective cellular microenvironment. They are equipped with an inherent molecular defense to detect changes that can precipitate and trigger an oncogenic cascade in the internal and external environment of cells. The process called anoikis unleashes many a characteristic molecular change in the cells which eventually program to cell death in response to cell detachment and inappropriate cellular attachment, both of which can otherwise potentiate the ability of cells to preferentially pursue a malignant course due to the release of molecular discipline which conforms them to a benign structural and functional spectrum. The initiation and propagation of signaling that serves as a switch to cell survival or cell death mediated by surveillance of cell microenvironment is comprised of many heterogeneous sets of molecules interacting mainly at the interface of cell-extracellular matrix. Transforming cells continuously reprogram their signaling characteristics in sensing and modulating the stimuli from cell surface molecules like integrins, cadherins and immunoglobulin family of cell adhesion molecules at adhesion complexes, which enables them to resist anoikis and metastasize to different organs. Actin cytoskeleton binds BIM and Bcl2 modifying factor (BMF), which are regulated by the adhesion status and consequent conformation of cytoskeleton in the cells. This review aims at an integrated synopsis of fundamental mechanisms of the critical interactions of cell surface molecules to facilitate a focused analysis of the differential regulation of signaling processes at cell-ECM junctions that collectively rein the anoikis resistance, which in turn impacts metastatic aggressiveness and drug resistance of tumors originating from respective organs.
Copyright © 2010 UICC.

Entities:  

Mesh:

Year:  2010        PMID: 20949625      PMCID: PMC3292620          DOI: 10.1002/ijc.25725

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  114 in total

Review 1.  Cadherins in embryonic and neural morphogenesis.

Authors:  U Tepass; K Truong; D Godt; M Ikura; M Peifer
Journal:  Nat Rev Mol Cell Biol       Date:  2000-11       Impact factor: 94.444

2.  Hepatic tight junctions: from viral entry to cancer metastasis.

Authors:  Nikki P Lee; John M Luk
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 3.  PTEN and myotubularin: novel phosphoinositide phosphatases.

Authors:  T Maehama; G S Taylor; J E Dixon
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 4.  Oncogenic PI3K and its role in cancer.

Authors:  Yardena Samuels; Kajsa Ericson
Journal:  Curr Opin Oncol       Date:  2006-01       Impact factor: 3.645

5.  Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.

Authors:  R B Birge; J E Fajardo; C Reichman; S E Shoelson; Z Songyang; L C Cantley; H Hanafusa
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

6.  Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.

Authors:  Jerzy Nowak; Maria Mosor; Iwona Ziółkowska; Malgorzta Wierzbicka; Monika Pernak-Schwarz; Marta Przyborska; Krzysztof Roznowski; Andrzej Pławski; Ryszard Słomski; Danuta Januszkiewicz
Journal:  Eur J Cancer       Date:  2008-02-15       Impact factor: 9.162

7.  Keratinocytes in human wounds express alpha v beta 6 integrin.

Authors:  K Haapasalmi; K Zhang; M Tonnesen; J Olerud; D Sheppard; T Salo; R Kramer; R A Clark; V J Uitto; H Larjava
Journal:  J Invest Dermatol       Date:  1996-01       Impact factor: 8.551

8.  Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.

Authors:  Thiruvengadam Arumugam; Vijaya Ramachandran; Keith F Fournier; Huamin Wang; Lauren Marquis; James L Abbruzzese; Gary E Gallick; Craig D Logsdon; David J McConkey; Woonyoung Choi
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

9.  Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

Authors:  M S Talamonti; M S Roh; S A Curley; G E Gallick
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

10.  Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton.

Authors:  J R Glenney; L Zokas
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

View more
  33 in total

1.  Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo.

Authors:  Prabodh K Kandala; Sanjay K Srivastava
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

2.  Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.

Authors:  Yekaterina B Khotskaya; Benjamin H Beck; Douglas R Hurst; Zhenbo Han; Weiya Xia; Mien-Chie Hung; Danny R Welch
Journal:  Mol Carcinog       Date:  2013-09-02       Impact factor: 4.784

3.  Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells.

Authors:  Randi Wise; Sara Duhachek-Muggy; Yue Qi; Michal Zolkiewski; Anna Zolkiewska
Journal:  Breast Cancer Res Treat       Date:  2016-05-09       Impact factor: 4.872

4.  Detection of Anoikis Using Cell Viability Dye and Quantitation of Caspase Activity.

Authors:  Roslyn Tedja; Alexandra Fox; Ayesha B Alvero
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Influence of the microenvironment on cell fate determination and migration.

Authors:  Alexander B Bloom; Muhammad H Zaman
Journal:  Physiol Genomics       Date:  2014-03-11       Impact factor: 3.107

Review 6.  The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.

Authors:  Ulrich H Weidle; Steffen Dickopf; Corinna Hintermair; Gwendlyn Kollmorgen; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

Review 7.  Novel anti-cancer compounds for developing combinatorial therapies to target anoikis-resistant tumors.

Authors:  Lokesh Nagaprashantha; Neha Vartak; Sangeeta Awasthi; Sanjay Awasthi; Sharad S Singhal
Journal:  Pharm Res       Date:  2011-12-28       Impact factor: 4.200

8.  TGF-β upregulates miR-181a expression to promote breast cancer metastasis.

Authors:  Molly A Taylor; Khalid Sossey-Alaoui; Cheryl L Thompson; David Danielpour; William P Schiemann
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

9.  Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradation.

Authors:  Varisa Pongrakhananon; Todd A Stueckle; Hua-Yu Leo Wang; George A O'Doherty; Cerasela Zoica Dinu; Pithi Chanvorachote; Yon Rojanasakul
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

10.  Cell durotaxis on polyelectrolyte multilayers with photogenerated gradients of modulus.

Authors:  Jessica S Martinez; Ali M Lehaf; Joseph B Schlenoff; Thomas C S Keller
Journal:  Biomacromolecules       Date:  2013-04-02       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.